Multimodal monitoring combined with hypothermia for the management of severe traumatic brain injury: A case report

Abstract

Traumatic brain injury (TBI) is a prominent public health issue that has a significant negative impact on patients and their family members. It is the leading cause of mortality and disability among young (below 50 years old) individuals. Intracranial hypertension (ICH) remains the single most difficult therapeutic challenge for the management of severe TBI. Therapeutic hypothermia may reduce intracranial hypertension and improve patient outcomes; however, the use of hypothermia is controversial. It has been reported that therapeutic hypothermia elicits no therapeutic benefit for patients with TBI. The present study presents two patients with severe(s) TBI who were admitted to 101st Hospital of the People's Liberation Army Between June 2017 to October 2017. Multimodal brain monitoring measurements of intracranial pressure, cerebral perfusion pressure (CPP) and bispectral index (BIS) were used during assisted hypothermia for management of patients with sTBI. The duration, degree of hypothermia treatment and speed of re-warming were assessed.

Introduction

Traumatic brain injury (TBI) has a high morbidity and has a significantly negative impact on the lives of patients and their families (1–4). The U.S. Centers for Disease Control and Prevention reported that the combined incidence of TBI-associated hospitalizations, emergency department visits and mortality was 823.7 per 100,000 in 2010 (5). Intracranial hypertension (ICH) is an important predictor of mortality in patients with severe TBI and patient outcomes and mortality can be improved if the ICH is well managed (6–8). In a meta-analysis, Sadaka and Veremakis (8) reported the effectiveness of mild-to-moderate therapeutic hypothermia in controlling ICH in patients with severe TBI. The use of therapeutic hypothermia as a neuroprotective strategy was first reported in the 1940s (9). A number of studies have demonstrated that therapeutic hypothermia is useful for improving patient outcomes and reducing mortality (10–12). Furthermore, recently published randomized trials reported that hypothermia had no therapeutic benefit in terms of mortality or morbidity (13–15). Variation between studies, including in the duration and degree of hypothermia, may impact their clinical efficacy.

Multimodal brain monitoring is an important tool that may provide key information to guide the management of severe TBI in adults (16,17). A number of studies have reported the use of non-invasive multimodal brain monitoring of continuous electroencephalography and the bispectral index (BIS) in the treatment of patients with severe TBI (sTBI) patients; these parameters may allow for the development of patient-tailored treatments and help to determine when the brain is at risk of injury and the depth of sedation required (18–20).

The present study presents two patients with sTBI who were admitted to the Center for Craniocerebral Injuries of the 101st Hospital of the People's Liberation Army (Wuxi, China). Additionally, the present study mainly focused on the value of multimodal monitoring combined with the effectiveness of hypothermia management of sTBI.

Case report

Case one

A 17-year-old female was found unconscious on the stairs at her school in October 2016. The exact mechanism of injury was unclear. The patient was brought to the emergency department of the 101st Hospital of the People's Liberation Army by ambulance within 15 min of being found. Upon arrival of the patient, an arterial line and central venous catheters were inserted for fluid and medication administration and her vital signs, ultrasonography and electroencephalography (EEG) were monitored. Emergency treatment comprised endotracheal intubation to improve hypoxia and administration of mannitol (250 ml, 20%) and hypertonic saline (100 ml, 7.5%) to improve cerebral hernia. The patient was examined and a Glasgow Coma Scale (GCS) score of 4 was determined, as well as 4.0 mm bilaterally fixed pupils and a negative corneal response. A cranial computed tomography (CT) scan revealed subarachnoid hemorrhage, left occipital bone fracture, right subdural hematoma, compressed cisterns and a notable midline shift (Fig. 1A). The patient was prepared for surgery and an intracranial pressure (ICP) probe was implanted.

Figure 1.

A 17-year-old girl presented with a head injury of unknown origin. (A) Cranial CT revealed subarachnoid hemorrhage, left occipital bone fracture (red arrow), right subdural hematoma, compressed cisterns and obvious midline shift. (B) Intraoperative ultrasound and intraoperative cranial CT revealed occipital epidural hematoma (red arrow). (C) Postoperative CT was used to confirm removal of the hematoma and improvement of the midline shift. (D) On day 3 post-surgery, cranial CT revealed brain swelling and compressed cisterns. (E) ICP and PI over a 10-day period. (F) At 23 days post-surgery, a cranial CT scan revealed complete absorption of the edema and hematoma. CT, computed tomography; ICP, intracranial pressure; PI, pulsatility index; EEG, electroencephalography.

The ICP prior to surgery was recorded as 47 mmHg. The patient underwent a craniotomy and right-sided decompressive craniotomy. The hematoma was removed and the ICP decreased to 5 mmHg; however, intraoperative ICP monitoring revealed that the ICP progressively increased to 18 mmHg within 1 h. Intraoperative ultrasound and intraoperative CT scan confirmed an occipital epidural hematoma (Fig. 1B). The original incision was extended to remove the epidural hematoma and the ICP returned to 5 mmHg. The patient was subsequently transferred to the neurointensive care unit (NICU) where she underwent a postoperative examination and received continuous BIS, ICP, CPP and ultrasound monitoring under the care of a neurosurgeon and an intensivist. The patient's GCS post-surgery was 5 and the bilateral pupils were 4.0 mm with a negative corneal response. A subsequent cranial CT scan revealed an improvement of the midline shift (Fig. 1C).

During the first 24 h following admission, the primary aim was of treatment was to improve the internal environment and address any coagulation disorders. Following a 24 h admission, the CPP and ICP were normal (65–80 and 15–20 mmHg, respectively). The patient's BIS was 55–65 and ultrasound revealed a pulsatility index (PI) ~1.35.

On the second day following admission, the patient's ICP increased to 25 mmHg, CPP decreased to 55–70 mmHg and PI increased to 1.6. The patient received analgesia (Fentanyl Citrate, 0.001 mg/kg per 4 h), sedation (Dexmedetomidine, 0.1 µg/kg per hour) and hypertonic salt (4.5% NaCl) treatment. Following 6 h of treatment, the ICP decreased to 17 mmHg.

On the third day, the patient's ICP increased to 35 mmHg and the she presented a higher PI (2.3) and lower CPP (45–65 mmHg). CT scans revealed brain swelling (Fig. 1D). At this point, hypothermia was implemented to control the ICP until coagulation patterns returned to normal. The specific treatment parameters were as follows: Temperature, 36°C; target ICP, ~20 mmHg; target CPP, ~70 mmHg.

During the fourth day, ICP, CPP and PI were poorly controlled; the patient's temperature was decreased to 35°C and she was deeply sedated with a lower BIS (40–50) and placed on a ventilator. The ICP, PI and CPP subsequently returned to normal levels and were within acceptable ranges. The patient was subjected to hypothermic treatment for a total of 10 days (Fig. 1E).

At 23 days post-injury, the patient had complete resolution of disease with mild language disorders and a GCS score of 4. A cranial CT scan revealed that the edema and hematoma were no longer present (Fig. 1F).

In this case, multimodal brain monitoring was used to provide important information and insight about the patient's condition, allowing for precise treatment of TBI. Intraoperative ultrasound may contribute to a quick diagnosis and better surgical planning. ICP, CPP, BIS and PI monitoring may provide additional information and support during the initiation and management of hypothermia, minimizing complications and maximizing the efficacy of treatment.

Case two

A 55-year-old male was rendered unconscious following a fall from a great height (8 m) at his place of work. The patient was admitted to the emergency department at a Level 2 hospital (Huishan People's hospital, Wuxi, China) via ambulance in May 2016, within 30 min of injury. Physical examination revealed a GCS of 6 and 3 mm bilateral pupils with a normal light reflex. A cranial CT scan revealed subarachnoid hemorrhage, bilateral subdural hemorrhage and severe cranial comminuted fractures (Fig. 2A). The patient's initial ICP was 27 mmHg and he underwent a craniotomy to remove the hematoma and brain contusion. This patient did not receive decompressive craniectomy (DC) as ICP levels were 5 mmHg following surgery. The patient was subsequently sent to the NICU and postoperatively examined by a neurosurgeon, who reported a GCS of 7 and bilateral pupils at 3.0 mm with a positive corneal response. A cranial CT scan revealed improvement of the midline shift and complete removal of the brain contusion (Fig. 2B); however, the patient developed a high fever and blood coagulation disorders on the second day post-surgery and his ICP levels progressively increased to 28 mmHg. Due to the development of blood coagulation disorders and the patient's family not consenting to a second operation or DC.

Figure 2.

A 55-year-old man presented with head trauma following a workplace fall. (A) Cranial CT revealed subarachnoid hemorrhage, bilateral subdural hemorrhage and severe comminuted cranial fractures. (B) Postoperative cranial CT revealed improvement of the midline shift and removal of the brain contusion. (C) On day 1 post-surgery, cranial CT revealed brain swelling, cerebral ischemia and re-bleeding. (D) ICP and PI monitoring for 12 days. (E) At 30 days post-surgery, cranial CT revealed decreased cerebral ischemia and complete absorption of brain edema and hematoma. CT, computed tomography; ICP, intracranial pressure; PI, pulsatility index.

On the third day post-surgery, the patient's ICP levels were >37 mmHg and he was referred to the NICU at the 101st Hospital of the People's Liberation Army. When the patient arrived at the NICU multimodal monitoring was conducted as described in case 1 and the patient underwent an additional CT examination. A cranial CT scan revealed brain swelling, cerebral ischemia and re-bleeding (Fig. 2C). The ICP levels increased to 56 mmHg with a higher PI (3.4) and lower CPP (40–55 mmHg). At this point, hypothermia was implemented to control the ICP. The specific treatment parameters were as follows: Temperature, 34.5°C; target ICP, ~28 mmHg; target CPP, ~65 mmHg. However, no improvements were observed 1 day following the initiation of hypothermia and the patient presented with an ICP of ~33 mmHg. The patient was deeply sedated (general anesthesia, (Fentanyl Citrate, 0.001 mg/kg per 4 h), sedation (Dexmedetomidine, 0.1 µg/kg per hour), BIS ~45, no breathing- and respirator-assisted respiration). Subsequently, the ICP remained stable, >30 mmHg and the PI was <1.8. The duration of hypothermia treatment was 15 days (Fig. 2D).

At 30 days post-injury, the patient was discharged to a rehabilitation hospital (Huishan People's hospital, Wuxi, China) with a GCS of 10. Cranial CT re-examination revealed decreased cerebral ischemia and complete absorption of brain edema and hematoma (Fig. 2E).

In this case, ICP, CPP and PI were very important indices of TBI, which were the target of the hypothermia treatment conducted in the present study. ICP can be controlled by regulating the degree of hypothermia and the dose of dehydrant (mannitol, Beijing Double-Crane Pharmaceutical Co., Ltd., Beijing, China). BIS monitoring may reflect the depth of coma and sedation; additionally, the depth of sedation may be regulated to control ICP and reduce hypothermia-relevant complications.

Discussion

TBI is one of the most common ailments worldwide, with high morbidity and mortality, (6). Elevated ICP is an important predictor of mortality in patients with sTBI and controlling the ICP has been demonstrated to reduce mortality and improve patient outcome (6,21). However, methods used to control ICP require further investigation; DC and osmotic therapy are appropriate options (22); however, these treatments offer no significant curative effect following the administration of analgesia, sedation and osmotic therapy (22). Hypothermia is an alternative treatment that is able to effectively control ICP levels (8,10–12,23,24). Schreckinger and Marion (23) indicated that therapeutic moderate hypothermia was as effective or more effective than other treatments for ICH. Furthermore, there is no evidence of clinical complications associated with therapeutic hypothermia. Previous studies have stated that hypothermia does not confer a therapeutic benefit to mortality or morbidity (13–15,25,26). However, previous negative findings may be a result of inappropriate implementation of hypothermia, including the wrong duration and degree of treatment. Precise monitoring is necessary to evaluate the degree and duration of therapeutic hypothermia. Therefore, multimodal monitoring is an important tool that may provide support for patients who undergo hypothermia treatment. Both patients described in the present study received long-term mild to moderate hypothermia treatment and multimodal monitoring and ICP was successfully controlled.

The majority of multimodal brain monitoring methods are rapid and non-invasive and no particular contraindications are usually observed. Implantation of the ICP probe is an invasive operation that required minor injury; a small proportion of patients with blood coagulation disorders, old age or unstable vital signs may be unsuitable for ICP-monitored surgery (22). Therefore, multimodal brain monitoring may be highly applicable to the general population.

Multimodal brain monitoring is an important tool used for the rapid diagnosis of TBI. Ultrasound may provide a quick assessment of intracranial condition. In addition, BIS and PI may also aid in the determination of disease severity; however, CT scans are important for the analysis of TBI and cannot be replaced with other techniques. Additionally, multimodal brain monitoring has previously been employed to guide the management of sTBI. It is able to provide clinicians with an early indication of potential secondary complications in the recovering brain by identifying diagnostic features, including elevated ICP and decreased CPP (17) but may also aid the management of the target temperature and ICP. EEG and BIS serve important roles in the treatment of critically ill patients, particularly those suffering from sTBI and can improve their clinical outcome (19,27–30). Therefore, monitoring a barbiturate-induced coma using BIS is an interesting approach as it can provide a continuous suppression ratio and raw EEG traces, which enable monitoring of cerebral function (19). Bader et al (30) reported that the EEG-based technology in BIS monitors may be an additional tool that can be used in the ICU. The goal of BIS monitoring in sTBI is to reduce ICP and secondary injury, thereby improving patient outcome. BIS scores may reflect the depth of coma and sedation, which may then be regulated to control ICP. In the cases described in the present study, both patients underwent BIS monitoring to regulate the depth of sedation and control ICP; consequently, both patients had good treatment outcomes.

Ultrasonography is easy to use, noninvasive and is frequently used during early injury assessment, as well during the assessment of patients with sTBI and elevated ICP. Transcranial Doppler (TCD) ultrasonography is typically used to determine the PI of TCD waveforms (31). A significant correlation between CPP, ICP and PI has been reported (32,33) and Tan et al (32) suggested that TCD ultrasonography may be used to predict patient outcome at 6 months post-injury. Mayans et al (34) reported that serial TCD monitoring may allow for potentially fatal complications to be identified in time to allow a life-saving intervention in the ICU setting. A number of studies have reported that TCD ultrasonography is of great clinical value for measuring PI in the management of sTBI (34,35). Furthermore, it has been reported that PI correlates well with the ICP as measured using invasive methods (36). Amyot et al (31) summarized the role of TCD for the evaluation of ICH as follows: i) TCD waveform alterations indicate an abnormally high ICP, particularly 20 to 30 mmHg; ii) TCD alterations may indicate that the ICP probe is malfunctioning and alert NICU personnel; iii) abnormally and globally decreased patterns of CBFVs with increased PIs indicate the onset of diffuse intracranial hypertension; and iv) the sudden onset of asymmetrical CBFVs and PI alterations may indicate a potential midline shift. At present, ultrasonography is not a viable replacement for ICP as ICP monitoring is more accurate and may be performed continuously and in real time. Further randomized controlled trials studies are required to evaluate the ultrasonography as a potential substitute for ICP monitoring in sTBI.

The cases presented herein demonstrate that hypothermia is a highly useful tool for controlling malignant ICH in sTBI. The present study provides further evidence that multimodal monitoring is useful in the management and optimization of therapeutic hypothermia. Additionally, long-term mild hypothermia may improve sTBI patient outcomes. The ICP, PI and EEG appear to be associated with patient outcomes and may be used to guide treatment for TBI in the NICU. A large multicenter, prospective study is required to validate these results.

Funding

No funding was received.

Availability of data and methods

The analyzed data sets generated during the present study are available from the corresponding author on reasonable request.

Authors' contributions

LKY made substantial contributions to the design of the study. YHW made substantial contributions to the conception and design of the study. JHC made substantial contributions to the conception and design of the study, as well as the acquisition, analysis and interpretation of data. YNX made substantial contributions to the conception and design of the study, as well as the acquisition of data. PPL gave final approval of the version to be published and made substantial contributions to the conception and design of the study. JHC, YNX and PPL contributed in drafting the manuscript and revising it critically for important intellectual content. MJ contributed in drafting the manuscript and revising it critically for important intellectual content, as well as the collection of data.

Ethics approval and consent to participate

The present study was approved by the Medical Ethics Committee of the 101st Hospital of the People's Liberation Army. Written informed consent was obtained from all participants.

Consent for publication

All patients provided consent for publication.

Competing interests

The authors declare that they have no competing interests.